Physician profile
Lina Dobronevsky
NPI 1184366502
$4,330.89
in general payments reported to CMS, 2019-2025
18 companies · $2,733 in 2025
The $2,733 reported for 2025 was more than what 95% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,598 · 2025: $2,733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,480 · Travel and Lodging: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,480.07 |
| Travel and Lodging | $850.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $1,044.03 | 2024-2025 | Truelok, Tl-Hex Truelok Hexapod System, Physio-Stim |
| Trimed, INC. | $824.12 | 2025 | |
| Stryker Corporation | $556.13 | 2024-2025 | Flexband, Citrefix, 7 X 23mm Citrelock Implant |
| Smith+Nephew, INC. | $443.83 | 2024-2025 | Grafix, Oasis, Collagenase Santyl |
| Polynovo North America LLC | $214.50 | 2024-2025 | Novosorb Btm |
| Urgo Medical North America, LLC | $201.74 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Amgen INC. | $143.83 | 2025 | Krystexxa |
| Linvatec Corporation | $138.20 | 2024 | Biobrace 23mm |
| Lifenet Health | $133.69 | 2025 | Theragenesis Wound Matrix |
| Kerecis Limited | $123.24 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $120.29 | 2025 | Nuzyra |
| Biocomposites INC | $111.92 | 2025 | Stimulan |
| Averitas Pharma INC. | $78.39 | 2025 | Qutenza |
| Organogenesis INC. | $63.31 | 2025 | Apligraf, Puraply Wound Matrix |
| Bioventus LLC | $46.68 | 2024-2025 | Exogen Ultrasound Bone Healing System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $38.26 | 2025 | |
| Avita Medical Americas, LLC | $31.01 | 2025 | Cohealyx, Permeaderm, Recell |
| Polaris Technology Solutions LLC | $17.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lina Dobronevsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.